Expression of active Akt protects against tamoxifen-induced apoptosis in MCF-7 Cells

IUBMB Life

Volumn 58, Issue 11, 2006, Pages 664-669

  Shin, Incheol ^a,b   Arteaga, Carlos L ^a,c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b Hanyang University   (South Korea)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt signaling; Breast cancer cells; Tamoxifen

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; LUCIFERASE; PROTEIN KINASE B; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFECT; ENZYME ASSAY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOPLASMIC RETICULUM; ESTRADIOL; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; TAMOXIFEN; TRANSCRIPTION, GENETIC;

EID: 33750624634     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540601001681     Document Type: Article

References (21)

1. Datta, S. R., Brunet, A., and Greenberg, M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927.
2. Brazil, D. P., and Hemmings, B. A. (2001) Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26, 657-664.
3. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nunez, G. (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689.
4. Kops, G. J., and Burgering, B. M. (1999) Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J. Mol. Med. 77, 656-665.
5. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., and Reed, J. C. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321.
6. Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70.
7. Staal, S. P. (1987) Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc. Natl. Acad. Sci. USA 84, 5034-5037.
8. Ruggeri, B. A., Huang, L., Wood, M., Cheng, J. Q., and Testa, J. R. (1998) Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Mol. Carcinogen. 21, 81-86.
9. Ueda, Y., Wang, S., Dumont, N., Yi, J. Y., Koh, Y., and Arteaga, C. L. (2004) Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility. J. Biol. Chem. 279, 24505-24513.
10. Kurokawa, H., Lenferink, A. E., Simpson, J. F., Pisacane, P. I., Sliwkowski, M. X., Forbes, J. T., and Arteaga, C. L. (2000) Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res. 60, 5887-5894.
11. Busse, D., Doughty, R. S., Ramsey, T. T., Russell, W. E., Price, J. O., Flanagan, W. M., Shawver, L. K., and Arteaga, C. L. (2000) Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity. J. Biol. Chem. 275, 6987-6995.
12. Campbell, R. A., Bhat-Nakshatri, P., Patel, N. M., Constantinidou, D., Ali, S., and Nakshatri, H. (2001) Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J. Biol. Chem. 276, 9817 - 9824.
13. Vilgelm, A., Lian, Z., Wang, H., Beauparlant, S. L., Klein-Szanto, Ellenson, L. H., and Di Cristofano, A. (2006) Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice. Cancer Res. 66, 3375-3380.
14. Shin, I., Yakes, F. M., Rojo, F., Shin, N. Y., Bakin, A. V., Baselga, J., and Arteaga, C. L. (2002) PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nature Med. 8, 1145-1152.
15. Shin, I., Rotty, J., Wu, F. Y., and Arteaga, C. L. (2005) Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin alpha during G1 and prevents nuclear re-entry. J. Biol. Chem. 280, 6055-6063.
16. Riese, D. J. 2nd, and Stern, D. F. (1998) Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20, 41-48.
17. Jackson, T. A., Richer, J. K., Bain, D. L., Takimoto, G. S., Tung, L., and Horwitz, K. B. (1997) The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol. Endocrinol. 11, 693-705.
18. Yarden, Y., and Sliwkowski, M. X. (2001) Untangling the ErbB signalling network. Nature Rev. Mol. Cell Biol. 2, 127-137.
19. Berry, M., Nunez, A. M., and Chambon, P. (1989) Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA 86, 1218-1222.
20. Shin, I., Miller, T., and Arteaga, C. L. (2006) ErbB receptor signaling and therapeutic resistance to aromatase inhibitors. Clin. Cancer Res. 12, 1008s-1012s.
21. Simoncini T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., and Liao, J. K. (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407, 538-541.